Company · CIK 0001974915
Vestal Point Capital, LP
other
Exchange
—
Entity type
other
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 13F-HRVestal Point Capital, LP0001974915-26-000005 · 39.7 KBSEC(opens sec.gov)
- SCHEDULE 13G/ATaysha Gene Therapies, Inc.0000902664-26-002553 · 10.9 KBSEC(opens sec.gov)
- SCHEDULE 13G/ABicara Therapeutics Inc.0000902664-26-002552 · 10.8 KBSEC(opens sec.gov)
- SCHEDULE 13G/AEnliven Therapeutics, Inc.0000902664-26-002551 · 10.9 KBSEC(opens sec.gov)
- SCHEDULE 13G/AAlto Neuroscience, Inc.0000902664-26-002550 · 10.8 KBSEC(opens sec.gov)
- SCHEDULE 13G/AImmatics N.V.0000902664-26-002549 · 10.9 KBSEC(opens sec.gov)
- SCHEDULE 13G/AArcellx, Inc.0000902664-26-002548 · 10.2 KBSEC(opens sec.gov)
- SCHEDULE 13G/ADay One Biopharmaceuticals, Inc.0000902664-26-002547 · 10.5 KBSEC(opens sec.gov)
- SCHEDULE 13GBRIGHT MINDS BIOSCIENCES INC.0000902664-26-002546 · 15.2 KBSEC(opens sec.gov)
- SCHEDULE 13GNurix Therapeutics, Inc.0000902664-26-002545 · 15.2 KBSEC(opens sec.gov)
Insiders
No insiders on record.
Tickers
No tickers on record.
Addresses
business
632 BROADWAY SUITE 602
NEW YORK, NY, 10012
mailing
632 BROADWAY SUITE 602
NEW YORK, NY, 10012